34
Views
17
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

In Vitro Susceptibility of Community-Acquired Urinary Tract Pathogens to Commonly Used Antimicrobial Agents in Spain: a Comparative Multicenter Study (2002-2004)

Pages 263-270 | Published online: 18 Jul 2013
 

Abstract

The susceptibility patterns of 2724 uropathogens isolated in 9 Spanish regions during 2002, and 3013 obtained in 2004 were determined. The antibiotics tested were fosfomycin trometamol, amoxicillin, co-amoxiclav, cefixime, cefuroxime-axetil pipemidic acid, ciprofloxacin, trimethoprim plus sulphamethoxazole and nitrofurantoin.

Escherichia coli was the main pathogen in both studies (73% vs. 68.3%) followed by Proteus mirabilis (7.2% vs. 6.4%) and Klebsiella pneumoniae (5.4% vs. 5.2%). Enterococcus spp. (4.7% vs. 6.8%)Streptococcus agalactiae (1.7% vs.3.1%) and Staphylococcus saprophyticus (0.7% vs. 1.3%) were the most frequent Gram-positive pathogens. 31.3% of E. coli in 2002 and 32% in 2004 were susceptible to all antibiotics tested. Around 40% of E. coli were resistant to a single agent. 21.6-24.1% were resistant to two antibiotics. 35.4% of first period isolates, and 37.6% of second period ones were resistant to two or more classes of antibiotics. Fosfomycin (2.1- 2.8%) and nitrofurantoin (3.5-5.7%) had the lowest resistance rates for E. coli. Amoxicillin (58.2-58.7%), co-trimoxazole (30.8-33.8%) and ciprofloxacin (22.6-22.7%) showed the highest resistance rates, and their suitability as empiric treatments for UTI should probably be re-evaluated.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.